Risk factors for the development of pleural empyema in children

Mohamed A Elemraid1,2, Matthew F Thomas3,4, Alasdair P Blain3

  • 1Department of Paediatric Infectious Disease and Immunology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Pediatric Pulmonology
|April 3, 2014
PubMed

Insights

Pediatric pleural empyema is rising, with ibuprofen use and bacterial infection identified as key risk factors in children with pneumonia. Further research is needed to understand ibuprofen

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonary Medicine
  • Epidemiology

Background:

  • Pediatric pleural empyema incidence has significantly increased over the last two decades.
  • The underlying reasons for this rise in childhood empyema are not fully understood.

Purpose of the Study:

  • To investigate potential risk factors associated with the development of empyema in children hospitalized with community-acquired pneumonia.
  • To analyze demographic, clinical, socioeconomic, and epidemiological factors, including ibuprofen use, in pediatric empyema cases.

Main Methods:

  • Prospective etiological study of 160 hospitalized children (≤16 years) with radiologically confirmed pneumonia.
  • Data collection included patient demographics, clinical presentation, pre-hospitalization medication use (ibuprofen), and potential risk factors.
  • Statistical analysis, including odds ratios (OR) with 97.5% credible intervals, was used to compare children with and without empyema.

Main Results:

  • Empyema developed in 25% (40/160) of the children.
  • Children who developed empyema were more likely to have received ibuprofen prior to hospital admission (82% vs. 46.2%; OR 1.94).
  • Confirmed bacterial infection was strongly associated with empyema development (OR 3.34). Age, sex, socioeconomic status, and parental smoking were not significant risk factors.

Conclusions:

  • Pre-hospitalization ibuprofen use and confirmed bacterial infection are associated with the development of empyema in children with pneumonia.
  • Further population-based studies are recommended to explore the role of ibuprofen in modulating disease course in pediatric pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
6.3K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.1K